Deutsche Bank Initiates Kymera Therapeutics at Hold, With $120 Price Target

Northland Securities Initiates Coverage on NeoVolta With Outperform Rating, $15 Price Target

Northland Securities Initiates Coverage on NeoVolta With Outperform Rating, $15 Price Target

BofA Securities Upgrades Humana to Buy From Neutral, Raises Price Target to $500 From $410

Humana (HUM) has an average rating of hold and mean price target of $350.54, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $365.15, Change: $-23.56, Percent Change: -6.06%

Oppenheimer Initiates Quince Therapeutics at Outperform With $82 Price Target